In this issue:
- Disease burden of atopic dermatitis in patients in Australia and NZ
- Inflammasomes: Emerging therapeutic targets in HS?
- Effects of semaglutide in obese patients with HS
- Effects of spesolimab in patients with moderate to severe HS
- Safety of systemic vs topical corticosteroids in patients with bullous pemphigoid
- Remission dynamics and prognostic factors in lichen planopilaris
- Efficacy and safety of secukinumab in adults with lichen planus
- Time to relapse after withdrawal of different biologics in patients with psoriasis
- Adverse reactions to isotretinoin reported to CARM
- Association of inflammatory bowel disease with isotretinoin use
Please login below to download this issue (PDF)